EuBiologics Co (XKRX:206650) Total Liabilities : ₩51,487 Mil (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is EuBiologics Co Total Liabilities?

EuBiologics Co's Total Liabilities for the quarter that ended in Sep. 2024 was ₩51,487 Mil.

EuBiologics Co's quarterly Total Liabilities declined from Mar. 2024 (₩46,655.39 Mil) to Jun. 2024 (₩45,415.46 Mil) but then increased from Jun. 2024 (₩45,415.46 Mil) to Sep. 2024 (₩51,486.80 Mil).

EuBiologics Co's annual Total Liabilities increased from Dec. 2021 (₩33,174.95 Mil) to Dec. 2022 (₩42,630.83 Mil) and increased from Dec. 2022 (₩42,630.83 Mil) to Dec. 2023 (₩46,988.06 Mil).

EuBiologics Co Total Liabilities Historical Data

The historical data trend for EuBiologics Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EuBiologics Co Total Liabilities Chart

EuBiologics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

57,813.40

59,078.74

33,174.95

42,630.83

46,988.06

EuBiologics Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial															46,619.32	46,988.06	46,655.39	45,415.46	51,486.80

EuBiologics Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

EuBiologics Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	25698.835	+	(4345.788	+	16078.906
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	864.532)
	=	46,988

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	151805.703	-	104817.642
	=	46,988

EuBiologics Co's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	29880.279	+	(2200	+	17437.731
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	1968.79)
	=	51,487

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	175417.521	-	123930.722
	=	51,487

EuBiologics Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of EuBiologics Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

EuBiologics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EuBiologics Co Ltd (XKRX:206650) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

6F Bomnal-A-Chim B/D Mabang-ro 8, Seocho-gu, Seoul, KOR, 06778

Website

http://www.eubiologics.com

EuBiologics Co Ltd is a biopharmaceutical company, which develops and supplies vaccines for epidemics and antibiotic resistance in South Korea. It offers Euvchol, an oral cholera prevention vaccine; and CRM197, a diphtheria toxin mutant vaccine, Inaba Cairo, and among others.

EuBiologics Co Headlines

No Headlines